Session Information
AABB SAMs Courses 2012
Click here to go to the previous page
Controversies in Therapeutic Plasma Exchange Treatment for Multiple Sclerosis and Neuromyelitis Optica
Track
:
Sessions
Program Code:
9318-TC
Date:
Monday, October 8, 2012
Time:
2:00 PM to 3:30 PM
EST
Location:
258B/C
SPEAKER
(S):
Carolina Ionete, MD, PhD, Associate Professor of Clinical Neurology, Umass
A. Sergio Torloni, MD, Medical Director, Stem Cell Therapy, Therapeutic Apheresis, Mayo Clinic Hospital
Bruce McLeod, MD, Director, Blood Center, Rush University Medical Center
Description
Multiple sclerosis (MS) is a relapsing and often progressive disorder of the central nervous system characterized by demyelination. Some reports show that TPE is effective for acute MS; however, TPE is often performed for non-acute phase MS patients who are unresponsive to steroids with lack of evidence of effectiveness. On the other hand, NMO is considered as an autoimmune disease associated with NMO-IgG. The effect of TPE on NMO patients is not consistent and the demyelination of optic nerve can be a part of MS. This session will discuss controversial application of TPE on both diseases.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |